Robinson, Dennis
Mayo Clinic
Department of Health Sciences Research, Mayo Clinic, Rochester, MN.
Citations 3
Physical activity and the risk of non‐Hodgkin lymphoma subtypes: A pooled analysis
Boyle, Terry , Kleinstern, Geffen , Bracci, Paige M. , Cerhan, James R. , Benavente, Yolanda , Casabonne, Delphine , Holly, Elizabeth A., Liebow, Mark , Paltiel, Ora , Robinson, Dennis P. , Rothman, Nathaniel , Wang, Sophia , Weisenburger, Dennis D. , Spinelli, John J., Norman, Aaron, Paltiel, Ora , Robinson, Dennis, Rothman, Nathaniel , Cerhan, James R , Wang, Sophia S , Chiu, Brian C.‐H. , Habermann, Thomas M. , Norman, Aaron D. , Rothman, Nathaniel , Seir, Rania Abu , Slager, Susan L. , Villeneuve, Paul J.
International Journal of Cancer | August 27, 2022 | Volume: 152 | Issue: 3 | Pages: 396-407
AbstractNon‐Hodgkin lymphoma (NHL) is composed of a heterogeneous collection of subtypes with considerable differences in genetics, biology and aetiology. Studies to date on physical activity and NHL risk have not had sufficient sample size to evaluate whether associations differ by subtype. We pooled data from nine case‐control studies to examine the association between moderate‐to‐vigorous intensity physical activity (MVPA) and risk of NHL overall and by subtype (diffuse large B‐cell lymphoma, follicular lymphoma, chronic lymphocytic leukaemia/small lymphocytic lymphoma, marginal zone lymphoma and mature T‐cell lymphoma). A total of 5653 cases and 9115 controls were included in the pooled analysis. Physical activity was harmonised across nine studies and modelled as study‐specific tertiles. Multinomial logistic regression was used to estimate the association between physical activity and NHL, adjusting for confounders. The overall odds of NHL was 13% lower among participants in the most active tertile of MVPA compared to the least active tertile (adjusted odds ratio = 0.87, 95% CI = 0.80, 0.95). Similar decreases were observed across NHL subtypes. In summary, in this pooled analysis of case‐control studies, physical activity was associated with a modest risk reduction for each NHL subtype examined and with overall NHL.
The association of health behaviors with quality of life in lymphoma survivors
Pophali, Priyanka A. , Robinson, Dennis P. , Thanarajasingam, Gita , Call, Timothy G. , Allmer, Cristine, Farooq, Umar , Maurer, Matthew J. , Yost, Kathleen J. , Thompson, Carrie A. , Rosenthal, Allison C, Robinson, Dennis, Thanarajasingam, Gita , Call, Timothy, Maurer, Matthew , Farooq, Umar , Pophali, Priyanka , Larson, Melissa C. , Rosenthal, Allison , Habermann, Thomas M. , Cerhan, James R.
Leukemia & Lymphoma | October 13, 2020 | Volume: 62 | Issue: 2 | Pages: 271-280
Association of polygenic risk score with the risk of chronic lymphocytic leukemia and monoclonal B-cell lymphocytosis
Kleinstern, Geffen , Camp, Nicola J. , Goldin, Lynn R. , Vachon, Celine M. , Vajdic, Claire M. , Sanjosé, Sílvia de, Weinberg, J. Brice , Benavente, Yolanda , Casabonne, Delphine, Liebow, Mark , Nieters, Alexandra, Hjalgrim, Henrik , Melbye, Mads , Glimelius, Bengt , Adami, Hans‐Olov , Brennan, Paul , McKay, James , Cocco, Pier Luigi, Call, Timothy G. , Hanson, Curtis A. , Robinson, Dennis P. , Chaffee, Kari G. , Brooks‐Wilson, Angela , Monnereau, Alain, Clavel, Jacqueline , Glenn, Martha, Curtin, Karen , Conde, Lucía , Bracci, Paige M. , Morton, Lindsay M. , Severson, Richard K., Chanock, Stephen J., Spinelli, John J., Johnston, James B. , Rothman, Nathaniel , Skibola, Christine F., Leis, José F., Smedby, Karin E. , Berndt, Sonja I. , Caporaso, Neil E., Rabe, Kari G. , Cocco, Pierluigi , Monnereau, Alain , Norman, Aaron D. , Hanson, Curtis, Robinson, Dennis, Cocco, Pierluigi , Brooks-Wilson, Angela R , Vajdic, Claire M , Morton, Lindsay M , Clavel, Jacqueline , Vachon, Celine M. , Casabonne, Delphine , Boffetta, Paolo , Maynadié, Marc , Shanafelt, Tait D. , Cozen, Wendy , Rothman, Nathaniel , Kay, Neil E. , Cerhan, James R. , Slager, Susan L.
Blood | April 19, 2018 | Volume: 131 | Issue: 23 | Pages: 2541-2551
Key Points PRS, based on the known CLL loci, predicts CLL risk with high discrimination. This PRS predicts risk of monoclonal B-cell lymphocytosis, a precursor to CLL and a condition that has clinical impact beyond risk for CLL.